Reproductive Health_YHLO

YHLO

YHLO

Language

Reproductive Health

Home page

2024/06/05

Impacts of ovarian reserve on conservative treatment for endometrial cancer and atypical hyperplasia

2024/06/05

The Correlation of Urine Bisphenol A with Semen Parameters in Men Referred to Infertility Centers A Cross-Sectional Study

2024/06/05

Comparison of sperm parameters and DNA fragmentation index between infertile men with infection and vaccines of COVID-19

2024/06/05

Identification and characterization of novel compound heterozygous variants in FSHR causing primary ovarian insufficiency with resistant ovary syndrome

2024/06/05

Protein palmitoylation-mediated palmitic acid sensing causes blood-testis barrier damage via inducing ER stress

2024/06/05

Serum anti-Müllerian hormone levels are associated with early miscarriage in the IVFICSI fresh cycle

2024/06/05

Semen parameters in men recovered from COVID-19

2024/06/05

Clinical Application Value of Inhibin B alone or in combination with other hormone indicators in Subfertile Men with Different Spermatogenesis Status A Study o

2024/06/05

Age-specific definition of low anti-Mullerian hormone and associated pregnancy outcome in women undergoing IVF treatment

2024/06/05

A visualized clinical model predicting good quality blastocyst development in the first IVFICSI cycle

< 1 2 >

YHLO

Home
Products
- CLIA
  - Analyzers
  - Reagents
- Chemistry
- TLA
- LIA
- ESR
Pubilcations
- Autoimmunity
- Reproductive Health
- Diabetes
- Liver Disease
- Infection
- COVID-19
- ESR
- Others
News
- YHLO News
About YHLO
Contact us
- Career
- Service

Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China

Tel: +86 755 26601910

Email: marketing@szyhlo.com

youtube

instagram

wechat

wechat

Copyright© 2024 Shenzhen YHLO Biotech Co., Ltd.

Powered by 300.cn | SEO | Business License

8

Email

marketing@szyhlo.com

9

Tel

+86 755 26601910